首页> 外文期刊>Advances in Infectious Diseases >Review of the Prognosis Factors of COVID-19 Infection
【24h】

Review of the Prognosis Factors of COVID-19 Infection

机译:审查Covid-19感染的预后因子

获取原文
           

摘要

An epidemic of Coronavirus disease 2019 (COVID-19) outbroke in December 2019 in China, Wuhan, which is becoming a Public Health Emergency of International Concern. As this entity has become one of the worst infectious disease outbreaks of recent times, with mortality estimates in general population ranging from 1.4% to 8%, it is crucial to better understand the prognostic factors which can be associated to the outcome of this disease. However, as the pandemic is still unfortunately under progression, there are limited data with regard to the prognostic factors. Hence, this review seeks to gather and provide the existing data of the literature of all the prognosis factors of COVID-19 infection such as older age, obesity, comorbidities, lymphocytopenia, d-dimers elevation, thrombocytopenia, elevated levels of high-sensitivity cardiac troponin, C-reactive protein elevation and imaging features of COVID-19.
机译:2019年12月在2019年12月在中国武汉的冠状病毒疾病疫情(Covid-19)开幕,正在成为国际问题的公共卫生应急。 由于该实体已成为最近次爆发的最糟糕的传染病爆发之一,但总体群体的死亡率估计范围从1.4%到8%,这对更好地了解可能与该疾病结果相关的预后因素至关重要。 然而,随着大流行仍然不幸的是进展,关于预后因素的数据有限。 因此,审查旨在收集和提供Covid-19感染的所有预后因素的文献的现有数据,例如老年人,肥胖症,组合,淋巴细胞缺乏症,D型升高,血小板减少,高敏感性心脏升高 Covid-19的肌钙蛋白,C反应蛋白质高度和成像特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号